These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6137384)

  • 1. Pharmacological agents to aid the clinician in combating myocardial ischaemia.
    Parratt JR
    Eur Heart J; 1983 Jul; 4 Suppl D():91-9. PubMed ID: 6137384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion.
    Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F
    Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reperfusion-induced ventricular fibrillation. Modification by pharmacological agents.
    Manning AS; Crome R; Isted K; Coltart DJ; Hearse DJ
    Adv Myocardiol; 1985; 6():515-28. PubMed ID: 2581300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid cascade and the generation of ischemia- and reperfusion-induced ventricular arrhythmias.
    Parratt JR; Coker SJ
    J Cardiovasc Pharmacol; 1985; 7 Suppl 5():S65-70. PubMed ID: 2410739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of secondary prevention after myocardial infarction. What have beta-blockers to offer in the experimental situation?
    Parratt JR
    Eur Heart J; 1986 Jul; 7 Suppl B():19-25. PubMed ID: 2875873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion.
    Parratt JR; Coker SJ; Wainwright CL
    J Mol Cell Cardiol; 1987 Oct; 19 Suppl 5():55-66. PubMed ID: 3323537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of myocardial ischaemia and the prevention of necrosis.
    Taylor RR
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():67-74. PubMed ID: 6126288
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs.
    Podzuweit T; Lubbe WF; Opie LH
    Lancet; 1976 Feb; 1(7955):341-2. PubMed ID: 54744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of beta-adrenergic blocking agents, i.v. nitrates and calcium channel blocking agents following acute myocardial infarction.
    Yusuf S
    Chest; 1988 Jan; 93(1 Suppl):25S-28S. PubMed ID: 2891466
    [No Abstract]   [Full Text] [Related]  

  • 10. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
    Ehring T; Heusch G
    Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9.
    Curtis MJ; Walker MJ
    Br J Pharmacol; 1988 Aug; 94(4):1275-86. PubMed ID: 3207985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and silent myocardial ischaemia.
    Steinbeck G
    Drugs; 1992; 43 Suppl 1():15-20. PubMed ID: 1378783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of catecholamines in the production of ischaemia-induced ventricular arrhythmias in the rat in vivo and in vitro.
    Daugherty A; Frayn KN; Redfern WS; Woodward B
    Br J Pharmacol; 1986 Jan; 87(1):265-77. PubMed ID: 2869812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary prevention in the post-infarction period].
    Corea L; Bentivoglio M
    Cardiologia; 1989 Feb; 34(2):127-33. PubMed ID: 2567624
    [No Abstract]   [Full Text] [Related]  

  • 16. Why Ca2+ antagonists will be most useful before or during early myocardial ischaemia and not after infarction has been established.
    Hugenholtz PG; Serruys PW; Fleckenstein A; Nayler W
    Eur Heart J; 1986 Apr; 7(4):270-8. PubMed ID: 2873037
    [No Abstract]   [Full Text] [Related]  

  • 17. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drugs blocking the calcium channel].
    Dabrowski M
    Kardiol Pol; 1982; 25(1):75-87. PubMed ID: 6285064
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic drugs: from mechanisms to clinical practice.
    Roden DM
    Heart; 2000 Sep; 84(3):339-46. PubMed ID: 10956304
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms involved in reperfusion arrhythmias.
    Verrier RL; Hagestad EL
    Eur Heart J; 1986 May; 7 Suppl A():13-22. PubMed ID: 3522236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.